Back To Top

Advancing Radiopharmaceutical R&D with the Canadian Nuclear Research Initiative – Health Stream

Canadian Nuclear Laboratories’ (CNL) is pleased to invite you to learn more about the Canadian Nuclear Research Initiative-Health Program (CNRI-H).

Canadian Nuclear Laboratories’ (CNL) Canadian Nuclear Research Initiative-Health Program (CNRI-H) was developed by CNL to further the realization of its mission by making its expertise, experience and capabilities available and accessible to the healthcare community to advance new life saving radiopharmaceutical therapies.

Join us for a webinar on February 22, 2024 at 12 p.m. EST

CNL’s Head of Directorate, Isotopes, Radiobiology and Environment, Dr. Marie-Claude Gregoire, will be joined by CNL’s Technical Director, Health, George Baidoo, to provide an overview of CNRI-H to help you understand if the program is right for your organization’s R&D needs. You’ll also hear from Jubilant Radiopharma’s Associate Director, R&D, Dr. Vijay Kuniyil Kulangara on the company’s firsthand experience with the program.

Webinar registration:

CNRI-H webinar registration